KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Invested Capital: 2010-2024

Historic Invested Capital for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $27.4 million.

  • TherapeuticsMD's Invested Capital rose 1.29% to $27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 1.29%. This contributed to the annual value of $27.4 million for FY2024, which is 6.55% down from last year.
  • Per TherapeuticsMD's latest filing, its Invested Capital stood at $27.4 million for FY2024, which was down 6.55% from $29.3 million recorded in FY2023.
  • Over the past 5 years, TherapeuticsMD's Invested Capital peaked at $113.7 million during FY2020, and registered a low of $27.4 million during FY2024.
  • Its 3-year average for Invested Capital is $30.6 million, with a median of $29.3 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first spiked by 1,135.70% in 2020, then crashed by 62.87% in 2022.
  • Yearly analysis of 5 years shows TherapeuticsMD's Invested Capital stood at $113.7 million in 2020, then declined by 16.75% to $94.6 million in 2021, then tumbled by 62.87% to $35.1 million in 2022, then fell by 16.66% to $29.3 million in 2023, then decreased by 6.55% to $27.4 million in 2024.